Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02593292
Other study ID # 69HCL14_0454
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 5, 2016
Est. completion date July 2018

Study information

Verified date February 2019
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This French multicentre open-label randomized trial will test the hypothesis that a coordinated health circuit based on obstetric risks, backed up by an electronic patient care reporting information system will optimize the continuum of pregnancy care monitoring. The electronic patient care reporting information system will be shared between patients, private practice physicians/midwifes, hospital physicians/midwifes and supervised by a coordinating midwife.


Recruitment information / eligibility

Status Completed
Enrollment 1532
Est. completion date July 2018
Est. primary completion date July 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients over the age of majority,

- enrolled in one of the two maternity hospitals in the study before 12 weeks of amenorrhea (SA) and 6 days (j) of age,

- affiliated to the National Health Insurance Fund of the country within the regional level health insurance

- have an internet access

Exclusion Criteria:

- illiterate patients,

- non-French speakers,

- under the age of majority,

- refusing to participate,

- without internet access,

- followed by one of these maternity wards but delivering else where,

- whose pregnancy ended in a miscarriage early or late (before 21 weeks of amenorrhea (SA) and 6 days (J) over).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
PROSPERO
The intervention is carried out in 3 steps: At the start of the pregnancy: a number of process steps are defined for a patient's pathway adapted to medical, obstetric and social risk factors. During pregnancy: city based doctors and midwives work together with their hospital peers enabling patients to participate through the reporting via a medical information system The entrance in the delivery room: patients are classified as low or high risk for greater vigilance from midwives.
Other:
control
At the start of the pregnancy, medical, obstetric and social risk factors are checked in the same way than the PROSPERO group. An adapted patient pathway was defined by a Clinical Research Assistant but unreachable from patients, midwifes and physicians. The electronic patient care reporting information system will be disabled and midwifes cannot create the classification checklist for low or high risk delivery.

Locations

Country Name City State
France Hôpital Femme Mère Enfant Bron
France Hospices Civils de Lyon Lyon

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of patients'pathway approved as compliant in the intervention group compared to the control group. Compliant patient pathways are those for which all actions (medical visits, examinations, …) recommended during pregnancy, according to the specific risk factors of each patient, will have been made. at the end of pregnancy
Secondary rate of severe maternal morbidity and mortality as defined by the EPIdémiologie de la MOrbidité Maternelle Sévère (EPINOMS) project From 22 completed weeks (154 days) of gestation to seven completed days after birth
Secondary rate of perinatal morbidity-mortality as defined by the Organization, Practices Evaluation in perinatal Network From 22 completed weeks (154 days) of gestation to seven completed days after birth
Secondary completeness of all hospital medical records completeness of hospital medical records compared to electronic patient-reported outcome (ePRO). the end of pregnancy (the date of delivery)
Secondary health care costs Number of medical visits and hospitalization one week from the date of delivery
Secondary health care costs duration of medical visits and hospitalization one week from the date of delivery
Secondary patients' satisfaction : Qualitative evaluation by interview Qualitative evaluation of patients' satisfaction and adherence by interview and/or focus groups. Quantitative evaluation of patients' satisfaction and anxiety by the hospital anxiety and depression scale and other validated's patient satisfaction forms at the end of pregnancy
Secondary patients' satisfaction : Quantitative evaluation by the hospital anxiety and depression scale Quantitative evaluation of patients' satisfaction and anxiety by the hospital anxiety and depression scale at the end of pregnancy
Secondary patients' satisfaction : Qualitative evaluation by interview Qualitative evaluation of patients' satisfaction and adherence by interview and/or focus groups. within one week from the date of delivery
Secondary patients' satisfaction : Quantitative evaluation by the hospital anxiety and depression scale Quantitative evaluation of patients' satisfaction and anxiety by the hospital anxiety and depression scale and other validated's patient satisfaction forms within one week from the date of delivery
Secondary types of delivery rate of vaginal delivery, instrumental extraction delivery, Caesarean delivery within one week from the date of delivery
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Terminated NCT02537145 - PregnanT Moms Measure - Do-It-Yourself Health Monitoring and Simulation of Health in Pregnant Women

External Links